Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Income from Continuing Operations (2023 - 2025)

SeaStar Medical Holding's Income from Continuing Operations history spans 3 years, with the latest figure at 2904000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 34.28% year-over-year to 2904000.0; the TTM value through Dec 2025 reached 12150000.0, up 51.07%, while the annual FY2025 figure was 12150000.0, 51.07% up from the prior year.
  • Income from Continuing Operations reached 2904000.0 in Q4 2025 per ICUCW's latest filing, up from 3472000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2002000.0 in Q2 2025 to a low of 12697000.0 in Q1 2024.
  • Average Income from Continuing Operations over 3 years is 5267666.67, with a median of 4095500.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: crashed 78.93% in 2024, then surged 70.29% in 2025.
  • A 3-year view of Income from Continuing Operations shows it stood at 9457000.0 in 2023, then soared by 53.27% to 4419000.0 in 2024, then skyrocketed by 34.28% to 2904000.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Income from Continuing Operations are 2904000.0 (Q4 2025), 3472000.0 (Q3 2025), and 2002000.0 (Q2 2025).